StockData
Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc. (ESTA) stock

ESTANasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$69.51−0.31 (-0.44%)

Close on Nov 17, 2026Market cap $2.07BP/E –Yield –

Establishment Labs profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Establishment Labs's profit margin for the twelve months ending Sep 30, 2026 was -14.6%. For fiscal 2025 it was -24.2%, against -51.0% the year before. The highest annual figure on record is -24.2% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-24.2%+26.8
FY2024Dec 31, 2024-51.0%−3.4
FY2023Dec 31, 2023-47.5%−1.0
FY2022Dec 31, 2022-46.5%−14.0
FY2021Dec 31, 2021-32.5%+12.5
FY2020Dec 31, 2020-45.0%−2.4
FY2019Dec 31, 2019-42.6%−8.1
FY2018Dec 31, 2018-34.5%+66.2
FY2017Dec 31, 2017-100.6%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-14.9%+5.8
Q2 FY2026Jun 30, 2026-17.4%+15.0
Q1 FY2026Mar 31, 2026-22.3%+27.7
Q4 FY2025Dec 31, 2025-4.0%+73.5
Q3 FY2025Sep 30, 2025-20.7%+20.7
Q2 FY2025Jun 30, 2025-32.3%+6.6
Q1 FY2025Mar 31, 2025-50.1%−6.5
Q4 FY2024Dec 31, 2024-77.6%−12.5
Q3 FY2024Sep 30, 2024-41.5%+34.6
Q2 FY2024Jun 30, 2024-38.9%−4.5
Q1 FY2024Mar 31, 2024-43.6%−17.9
Q4 FY2023Dec 31, 2023-65.1%−34.1
Q3 FY2023Sep 30, 2023-76.0%−27.4
Q2 FY2023Jun 30, 2023-34.5%+55.6
Q1 FY2023Mar 31, 2023-25.7%−10.2
Q4 FY2022Dec 31, 2022-31.0%+9.2
Q3 FY2022Sep 30, 2022-48.7%+1.9
Q2 FY2022Jun 30, 2022-90.1%−73.5
Q1 FY2022Mar 31, 2022-15.4%+7.5
Q4 FY2021Dec 31, 2021-40.2%−19.2
Q3 FY2021Sep 30, 2021-50.5%−31.9
Q2 FY2021Jun 30, 2021-16.6%+83.3
Q1 FY2021Mar 31, 2021-22.9%+49.6
Q4 FY2020Dec 31, 2020-21.0%+2.0
Q3 FY2020Sep 30, 2020-18.7%+37.2
Q2 FY2020Jun 30, 2020-100.0%−58.3
Q1 FY2020Mar 31, 2020-72.5%−20.6
Q4 FY2019Dec 31, 2019-22.9%+41.2
Q3 FY2019Sep 30, 2019-55.9%−63.9
Q2 FY2019Jun 30, 2019-41.7%−2.6
Q1 FY2019Mar 31, 2019-51.9%−7.8
Q4 FY2018Dec 31, 2018-64.1%−3.7
Q3 FY2018Sep 30, 20188.0%+153.8
Q2 FY2018Jun 30, 2018-39.1%+101.1
Q1 FY2018Mar 31, 2018-44.1%–
Q4 FY2017Dec 31, 2017-60.4%–
Q3 FY2017Sep 30, 2017-145.7%–
Q2 FY2017Jun 30, 2017-140.2%–

More Establishment Labs figures

See a number that looks wrong?